AHA

This channel contains news about the American Heart Association (AHA), including coverage of its annual meeting and guidelines. AHA is a leading resource for cardiology information, both consumer and professional.

The American Heart Association has issued a new Policy Statement focused on the need to address structural racism as a central component to reducing cardiovascular disparities across the United States.

News | AHA

American Heart Association New Policy Statement: Addressing Structural Racism Central to Reducing U.S. Cardiovascular Disease Disparities

January 18, 2024 — A new American Heart Association (AHA) policy statement examines the history of structural racism ...

January 18, 2024

Substance use disorder may be linked to more deaths from infective endocarditis among people ages 25-44, finds new study in Journal of the American Heart Association

News | Heart Valve Technology

Deaths from Heart Valve Infections Drop Across US Overall, but Surged Among Young Adults

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

December 18, 2023

ACC/AHA issue new Guideline for preventing and optimally managing common heart rhythm problem

News | Atrial Fibrillation

Early Rhythm Control, Lifestyle Modification and More Tailored Stroke Risk Assessment Are Top Goals in Managing Atrial Fibrillation

December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several ...

December 08, 2023

News | Cardiovascular Education

Minneapolis Heart Institute Foundation Research Advances Understanding of Health Equity and Outcomes in Fourth-Trimester Care for Women

December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular ...

December 04, 2023

A Prespecified, Exploratory Analysis of Participants Reports Those with Higher Baseline Inflammation More Likely to Experience a Major Cardiovascular Event (MACE), Cardiovascular Death, and All-Cause Mortality Compared to Those with the Lowest Inflammation

News | Cardiovascular Clinical Studies

Esperion Presents CLEAR Outcomes Analysis of Inflammation as Predictor of Cardiovascular Risk at American Heart Association Scientific Sessions 2023

November 27, 2023 — Esperion announced the presentation of results from a pre-specified, exploratory analysis of CLEAR ...

November 27, 2023

News | Atrial Fibrillation

Positive Results from ReVeRA Phase 2 Study of Etripamil Nasal Spray in AFib-RVR Presented by Milestone Pharmaceuticals during AHA 2023

November 24, 2023 — During the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA, Mi ...

November 22, 2023

News | Pharmaceuticals

BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

November 21, 2023

Investigators in the Smidt Heart Institute found that electrocardiogram changes picked up over time could indicate increased risk

News | Sudden Cardiac Arrest

Cedars-Sinai Investigators Move Closer to Predicting Sudden Cardiac Arrest

November 17, 2023 — Sudden cardiac arrest remains a deadly and complex condition, but investigators in the Smidt Heart ...

November 17, 2023

In the trial of more than 400 adults with heart failure in Israel, the app predicted the need for hospitalization about three weeks in advance of a heart failure event

News | Heart Failure

AI-phone App Detected Worsening Heart Failure Based on Changes in Patients’ Voices

November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a person ...

November 16, 2023

Real-world evidence from the AHA Scientific Sessions 2023 demonstrated that Eko's AI doubles valvular heart disease detection sensitivity over traditional methods

News | Wearables

Multicenter Validation of the Novel Vivio System for Non-Invasive Estimation of Elevated Left Ventricular End Diastolic Pressure

November 15, 2023 — Ventric Health, a healthcare technology company and medical device provider focused on ...

November 15, 2023

The award recognizes leaders who have made major contributions to the fields of cardiovascular and stroke science

News | Heart Failure

American Heart Association Honors Gladstone President Deepak Srivastava with Distinguished Scientist Award

November 14, 2023 — Deepak Srivastava, MD, president of Gladstone Institutes and a renowned cardiovascular researcher ...

November 14, 2023

News | Artificial Intelligence

Breakthrough Clinical Data: Eko Health's AI Significantly Improves Heart Disease Detection in Primary Care

November 14, 2023 — Eko Health, Inc., a leader in AI technology for heart and lung disease detection, today unveiled new ...

November 14, 2023

Research presented at AHA Scientific Sessions 2023 associates vMap’s use with significantly improved outcomes for unstable VT and surgical ablation of ventricular arrhythmias

News | AHA

Exciting New Applications of vMap for Ventricular Arrhythmias Highlighted at AHA 2023

November 13, 2023 — Vektor Medical, a pioneer in non-invasive arrhythmia analysis technology, is proud to highlight two ...

November 13, 2023

Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023, AHA 2023, which compared the effects of high-sodium and low-sodium diets on blood pressure in adults, found that following a low-sodium diet significantly lowered blood pressure in 70%-75% of participants in as little as one week

News | AHA

Reducing Sodium Intake Significantly Lowered Blood Pressure in as Little as One Week, Reports AHA 2023 Late-Breaking Science Abstract

November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific ...

November 11, 2023

Data from the randomized control trial will advance evidence for evaluation and treatment of heart disease by studying actual disease: atherosclerosis.

News | AHA

Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association AHA 2023 Scientific Sessions

November 11, 2023 — An announcement on partners to collaborate in the TRANSFORM trial was made today during the America ...

November 11, 2023